<unk>  (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca).<unk>  is sold as an acetate salt.
Pramlintide
Linaclotide
Insulin glulisine
Insulin degludec
Insulin detemir
Glibenclamide
Insulin aspart
Liraglutide